GeneCentric

GeneCentric's mission is to address the urgent need for better biomarkers in the field of precision oncology and apply these biomarkers to blood-based tests. By leveraging artificial intelligence (AI) and the inherently multimodal outputs of the GenomicsNext™ platform, we are accelerating advancements in cancer genomics.Building on over a decade of expertise in gene expression, GeneCentric has developed ExpressCT™, a breakthrough technology that utilizes information embedded in circulating tumor DNA (ctDNA) to measure gene expression, providing a more comprehensive liquid biopsy solution for precision medicine.